Correlation Between Entera Bio and ZyVersa Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entera Bio and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entera Bio and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entera Bio and ZyVersa Therapeutics, you can compare the effects of market volatilities on Entera Bio and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entera Bio with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entera Bio and ZyVersa Therapeutics.

Diversification Opportunities for Entera Bio and ZyVersa Therapeutics

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Entera and ZyVersa is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Entera Bio and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Entera Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entera Bio are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Entera Bio i.e., Entera Bio and ZyVersa Therapeutics go up and down completely randomly.

Pair Corralation between Entera Bio and ZyVersa Therapeutics

Given the investment horizon of 90 days Entera Bio is expected to generate 2.38 times less return on investment than ZyVersa Therapeutics. But when comparing it to its historical volatility, Entera Bio is 1.95 times less risky than ZyVersa Therapeutics. It trades about 0.05 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  118.00  in ZyVersa Therapeutics on November 9, 2024 and sell it today you would earn a total of  6.00  from holding ZyVersa Therapeutics or generate 5.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Entera Bio  vs.  ZyVersa Therapeutics

 Performance 
       Timeline  
Entera Bio 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Entera Bio are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Entera Bio showed solid returns over the last few months and may actually be approaching a breakup point.
ZyVersa Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ZyVersa Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, ZyVersa Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Entera Bio and ZyVersa Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entera Bio and ZyVersa Therapeutics

The main advantage of trading using opposite Entera Bio and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entera Bio position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.
The idea behind Entera Bio and ZyVersa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance